Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials
Background/purpose Atrial fibrillation (AF) is the most common arrhythmia worldwide. The sympathetic nervous system plays an important role in initiation and maintenance of AF. Recent studies have shown that renal sympathetic denervation (RSD) reduced AF recurrences after conventional pulmonary vein isolation (PVI). Studies that have evaluated the role of RSD as an adjuvant to PVI have included different patient populations, ablation strategies, and follow-up approaches. We performed a meta-analysis to assess the potential incremental impact of RSD to PVI. Methods We searched the databases of MEDLINE and EMBASE from inception to January 2020. Included studies were randomized controlled trials (RCTs) that compared the recurrence rates of AF in patients who underwent PVI and RSD versus PVI alone. Data from each study were combined using the random effects model to calculate odds ratios (OR) and 95% confidence intervals (CIs). Results Three RCTs consisted of four different studies during 2014–2020 involving 451 AF patients (223 patients underwent PVI alone and 228 patients underwent PVI with RSD) were included in the meta-analysis. Compared with PVI alone, the PVI with RSD group had a significantly lower risk of AF recurrence (pooled OR = 0.63, 95%CI 0.50–0.80, p < 0.001, I2 = 0.0%). There was no publication bias observed in funnel plot as well as no small-study effect observed in Egger’s test. Conclusions Our systematic review and meta-analysis demonstrated a significant reduction of AF recurrence in select hypertensive patients who underwent RSD in addition to PVI compared with PVI alone. Larger studies are needed to validate the benefits of this approach in other AF populations and across different ablation strategies..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of interventional cardiac electrophysiology - 60(2020), 3 vom: 12. Mai, Seite 459-467 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kewcharoen, Jakrin [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Atrial fibrillation |
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2020 |
|---|
| doi: |
10.1007/s10840-020-00748-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR044078366 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR044078366 | ||
| 003 | DE-627 | ||
| 005 | 20230519124254.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210520s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10840-020-00748-4 |2 doi | |
| 035 | |a (DE-627)SPR044078366 | ||
| 035 | |a (DE-599)SPRs10840-020-00748-4-e | ||
| 035 | |a (SPR)s10840-020-00748-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Kewcharoen, Jakrin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2020 | ||
| 520 | |a Background/purpose Atrial fibrillation (AF) is the most common arrhythmia worldwide. The sympathetic nervous system plays an important role in initiation and maintenance of AF. Recent studies have shown that renal sympathetic denervation (RSD) reduced AF recurrences after conventional pulmonary vein isolation (PVI). Studies that have evaluated the role of RSD as an adjuvant to PVI have included different patient populations, ablation strategies, and follow-up approaches. We performed a meta-analysis to assess the potential incremental impact of RSD to PVI. Methods We searched the databases of MEDLINE and EMBASE from inception to January 2020. Included studies were randomized controlled trials (RCTs) that compared the recurrence rates of AF in patients who underwent PVI and RSD versus PVI alone. Data from each study were combined using the random effects model to calculate odds ratios (OR) and 95% confidence intervals (CIs). Results Three RCTs consisted of four different studies during 2014–2020 involving 451 AF patients (223 patients underwent PVI alone and 228 patients underwent PVI with RSD) were included in the meta-analysis. Compared with PVI alone, the PVI with RSD group had a significantly lower risk of AF recurrence (pooled OR = 0.63, 95%CI 0.50–0.80, p < 0.001, I2 = 0.0%). There was no publication bias observed in funnel plot as well as no small-study effect observed in Egger’s test. Conclusions Our systematic review and meta-analysis demonstrated a significant reduction of AF recurrence in select hypertensive patients who underwent RSD in addition to PVI compared with PVI alone. Larger studies are needed to validate the benefits of this approach in other AF populations and across different ablation strategies. | ||
| 650 | 4 | |a Atrial fibrillation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Renal sympathetic denervation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pulmonary vein isolation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hypertension |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Vutthikraivit, Wasawat |e verfasserin |4 aut | |
| 700 | 1 | |a Rattanawong, Pattara |e verfasserin |4 aut | |
| 700 | 1 | |a Prasitlumkum, Narut |e verfasserin |4 aut | |
| 700 | 1 | |a Akoum, Nazem W. |e verfasserin |4 aut | |
| 700 | 1 | |a Bunch, T. Jared |e verfasserin |4 aut | |
| 700 | 1 | |a Navaravong, Leenhapong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of interventional cardiac electrophysiology |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1997 |g 60(2020), 3 vom: 12. Mai, Seite 459-467 |w (DE-627)SPR013631640 |w (DE-600)2006887-6 |x 1572-8595 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2020 |g number:3 |g day:12 |g month:05 |g pages:459-467 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10840-020-00748-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.85 |q ASE |
| 951 | |a AR | ||
| 952 | |d 60 |j 2020 |e 3 |b 12 |c 05 |h 459-467 | ||